Zhejiang Cancer Hospital

This early-stage study tests if cells from umbilical cord blood can safely help people with lung injury caused by chest radiation therapy. Ten adults aged 18-75 whose lung damage did not improve with standard care will receive the cell treatment. The goal is to see if it reduces …

This study will follow 500 women with epithelial ovarian, primary peritoneal, or fallopian tube cancer to see how safe and effective the drug senaparib is in real-world conditions. Participants will receive senaparib alone or with other treatments as decided by their doctor. The …

This study tests a new drug combination (Sac-TMT plus a targeted therapy, with or without radiation) in 45 adults with advanced non-small cell lung cancer that has spread to the brain and stopped responding to previous treatment. The goal is to see if the combination can control …

This study tests a new approach for people with a specific type of mid-to-low rectal cancer. Participants first receive a short course of radiation, then a drug called ivonescimab. The goal is to see if this combination can make the cancer disappear completely, possibly avoiding …

This study tests an oral form of the chemotherapy drug paclitaxel, taken daily or several times a week, for adults with advanced HER2-negative breast cancer. The trial has two parts: first, finding the safest dose of the oral paclitaxel alone, and then testing it combined with th…

This early-stage trial tests whether cells from umbilical cord blood can safely help people with long-term gut damage from radiation therapy. Ten adults aged 18-75 with moderate radiation enteritis will receive the treatment and be monitored for a year. The goal is to see if it r…

This observational study follows 300 premenopausal women with early HR-positive breast cancer who are already receiving ovarian function suppression (OFS) therapy. Researchers want to see how many women continue their treatment as prescribed and why some stop within two years. Th…